[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
October 23, 1967

Role of Anticoagulants in Preventing Embolization From Prosthetic Heart Valves

Author Affiliations

From the Division of Cardiothoracic Surgery and the Department of Hematology, Mount Sinai Hospital, New York.

JAMA. 1967;202(4):282-286. doi:10.1001/jama.1967.03130170082012
Abstract

In this study, 111 patients, discharged from the hospital after prosthetic heart valve replacement, were followed for evidence of embolization. Ninety-three patients received anticoagulant therapy and five had embolic episodes (5%). In contrast, systemic emboli developed in eight of 18 patients (44%) who were not given anticoagulants. Documented hemorrhagic complications occurred nine times and there were two other suspicious incidents. Prothrombin times during the occurrence of these complications were known in ten instances and were prolonged above therapeutic levels in nine of these cases. There have been eleven late deaths (10%). Precise anticoagulation appears to be of value in reducing thromboembolism from prosthetic valves. However, careful control is necessary to minimize hemorrhagic complications.

References
1.
Herr, R., et al:  Special Problems Following Valve Replacement ,  Ann Thorac Surg 1:403-410 ( (July) ) 1965.Crossref
2.
Effler, D.; Favaloro, R.; and Groves, L.:  Heart Valve Replacement: Clinical Experience ,  Ann Thorac Surg 1:4-24 ( (Jan) ) 1965.Crossref
3.
Davila, J., et al:  The Prevention of Thrombosis in Artificial Cardiac Valves ,  Ann Thorac Surg 2:714-740 ( (Sept) ) 1966.Crossref
4.
Starr, A.; Herr, R.; and Wood, J.:  Mitral Valve Replacement: A Review of Six Year's Experience , abstracted.  Amer Assoc Thorac Surg 4, 1967.
5.
van Cauwenberge, H., and Jaques, L.B.:  Hemorrhagic Effect of ACTH With Anticoagulant ,  Canad Med Assoc J 79:536-546, 1958.
6.
Mushett, C.W., and Seeler, A.O.:  Hypoprothrombinemia Resulting From the Administration of Sulfaquinoxaline ,  J Pharmacol Exp Ther 91:84, 1947.
7.
Link, K.P., et al:  Studies in the Hemorrhagic Sweet Clover Disease: XI. Hypothrombinemia in the Rat Induced by Salicylic Acid ,  J Biol Chem 147:463-474 ( (Feb) ) 1943.
8.
D'Angelo, G., and LeGresley, L.P.:  Severe Hypoprothrombinemia After Propylthiouracil Therapy ,  Canad Med Assoc J 81:479, 1959.
9.
Dayton, P.G., et al:  Influence of Barbiturates on Coumarin Plasma Levels and Prothrombin Response ,  J Clin Invest 40:1797-1802 ( (Oct) ) 1961.Crossref
10.
Carter, S.A.:  Potentiation of the Effect of Orally Administered Anticoagulant by Phenyramidol Hydrochloride ,  New Eng J Med 273:423 ( (Aug) ) 1965.Crossref
11.
Aggeler, P., et al:  Potentiation of Anticoagulant Effect of Warfarin by Phenylbutazone ,  New Eng J Med 276:496 ( (March) ) 1967.Crossref
12.
Luton, E.F.:  Carbon Tetrachloride Exposure During Anticoagulant Therapy: Dangerous Enhancement of Hypoprothrombinemia Effect ,  JAMA 194:1386-1387 ( (Dec 27) ) 1965.Crossref
×